MRC Holland is a biotechnology company well-known for its SALSA® MLPA® technology, the gold standard in the detection of gene copy number variation and epigenetics. MLPA assays are used worldwide to study hereditary disorders and tumours. In addition, MRC Holland also offers SALSA® digitalMLPA™, a technology offering unparalleled CNV detection in NGS, and a SALSA® Melt Assay for SMA newborn screening. The company’s mission to bring high quality CNV detection within reach for all relevant disorders has led to the development of over 300 different assays, all hallmarked by their ease-of-use and clear results.